February 19, 2024
Deutsche Bank bans remote work on Fridays and Mondays to evenly distribute presence throughout the week, away from typical mid-week concentration. Move may risk employee engagement and retention. US office vacancy rates rise due to remote work. Huge real estate value losses predicted globally.
Remote work: Deutsche Bank bans workers from working Fridays and Mondays at home | Fortune Fortune
February 19, 2024
US healthcare system predominantly focuses on high-intensity specialties, ignoring primary care, despite its potential in managing chronic diseases. The system sees exorbitant spending, with large non-profit organizations amassing wealth in hedge funds. Despite these numerous monetary reserves, these organizations resort to bailouts in crises. This system doesn't prioritize community health, with many lacking access to primary care, prompting large retailers' entry into primary care provision. Author encourages reevaluation of funds' allocation, reallocating it towards areas which need it most.
The Money’s in the Wrong Place. How to Fund Primary Care The Healthcare Blog
February 19, 2024
Microsoft will retire Azure IoT Central by March 31, 2027, halting new application creation from April 2024 while keeping existing apps functional. The IoT Central is an IoT aPaaS that reduces work and costs of building, managing, and maintaining IoT solutions. IoT Central is a part of Microsoft's Azure IoT offering consisting of IoT Hub, IoT Edge, and IoT Central. The company hasn't specified if IoT Hub and IoT Edge will continue.
Microsoft 'retires' Azure IoT Central in platform rethink The Register
February 19, 2024
FDA approves Omalizumab (Xolair) to reduce food allergy reactions. Effective in trial subjects with multiple allergies, blocks allergic responses by binding immunoglobulin E. Not universal cure, continued vigilance required. Long-term effectiveness and combination with oral immunotherapy being researched. Side effects include injection reactions, fever, potential pain, infections, malignancies.
New FDA-approved drug makes severe food allergies less life-threatening Ars Technica
© Copyright 2024 Health Lyrics All rights reserved
